FGF-2 Polyclonal Antibody
¥680.00
- 产品信息
商品描述
靶点-Target
TAB1
反应性
Human,Mouse,Rat,Bovine,Dog,Pig
应用
WB
宿主物种-Host Species
Mouse
修饰-Modification
Unmodified
MW(Calculated)
55kD
推荐稀释比
WB 1:1000-1:2000;Not yet tested in other applications.
组成
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
纯化工艺
Affinity purification
储存
-15°C to -25°C/1 year(Do not lower than -25°C)
克隆性
Monoclonal
免疫原
Purified recombinant human TAB1 (N-terminus) protein fragments expressed in E.coli.
特异性
TAB1 Monoclonal Antibody detects endogenous levels of TAB1 protein.
基因名称
TAB1
蛋白名称
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1
别名
TAB1;MAP3K7IP1;TGF-beta-activated kinase 1 and MAP3K7-binding protein 1;Mitogen-activated protein kinase kinase kinase 7-interacting protein 1;TGF-beta-activated kinase 1-binding protein 1;TAK1-binding protein 1
Organism-1
Human
基因ID-1
10454
SwissProt-1
Q15750
Organism-2
Mouse
基因ID-2
66513
SwissProt-2
Q8CF89
背景
The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced tr
细胞定位
nucleoplasm,cytoplasm,cytosol,endosome membrane,protein complex,
